Kevin Comcowich - Net Worth and Insider Trading

Kevin Comcowich Net Worth

The estimated net worth of Kevin Comcowich is at least $1,465 dollars as of 2024-09-22. Kevin Comcowich is the Director of Arcadia Biosciences Inc and owns about 500 shares of Arcadia Biosciences Inc (RKDA) stock worth over $1,465. Details can be seen in Kevin Comcowich's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kevin Comcowich has not made any transactions after 2019-09-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Kevin Comcowich

To

Kevin Comcowich Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kevin Comcowich owns 1 companies in total, including Arcadia Biosciences Inc (RKDA) .

Click here to see the complete history of Kevin Comcowich’s form 4 insider trades.

Insider Ownership Summary of Kevin Comcowich

Ticker Comapny Transaction Date Type of Owner
RKDA Arcadia Biosciences Inc 2019-09-17 director

Kevin Comcowich Latest Holdings Summary

Kevin Comcowich currently owns a total of 1 stock. Kevin Comcowich owns 500 shares of Arcadia Biosciences Inc (RKDA) as of September 17, 2019, with a value of $1,465.

Latest Holdings of Kevin Comcowich

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RKDA Arcadia Biosciences Inc 2019-09-17 500 2.93 1,465

Holding Weightings of Kevin Comcowich


Kevin Comcowich Form 4 Trading Tracker

According to the SEC Form 4 filings, Kevin Comcowich has made a total of 0 transactions in Arcadia Biosciences Inc (RKDA) over the past 5 years. The most-recent trade in Arcadia Biosciences Inc is the acquisition of 125 shares on September 17, 2019, which cost Kevin Comcowich around $29,400.

Insider Trading History of Kevin Comcowich

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kevin Comcowich Trading Performance

GuruFocus tracks the stock performance after each of Kevin Comcowich's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin Comcowich is -5.17%. GuruFocus also compares Kevin Comcowich's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin Comcowich within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kevin Comcowich's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kevin Comcowich

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -22.79 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -21.97 LIMIT LIMIT LIMIT LIMIT LIMIT

Kevin Comcowich Ownership Network

Ownership Network List of Kevin Comcowich

No Data

Ownership Network Relation of Kevin Comcowich

Insider Network Chart

Kevin Comcowich Owned Company Details

What does Arcadia Biosciences Inc do?

Who are the key executives at Arcadia Biosciences Inc?

Kevin Comcowich is the director of Arcadia Biosciences Inc. Other key executives at Arcadia Biosciences Inc include Chief Financial Officer Thomas J. Schaefer , Chief Executive Officer Stanley Jr Jacot , and Chief Financial Officer Pamela Haley .

Arcadia Biosciences Inc (RKDA) Insider Trades Summary

Over the past 18 months, Kevin Comcowich made no insider transaction in Arcadia Biosciences Inc (RKDA). Other recent insider transactions involving Arcadia Biosciences Inc (RKDA) include a net purchase of 2,049 shares made by Thomas J. Schaefer , a net purchase of 5,000 shares made by Stanley Jr Jacot , and a net purchase of 700 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Arcadia Biosciences Inc (RKDA) in total and bought 1,400 shares, with a net purchase of 1,400 shares. During the past 18 months, 0 shares of Arcadia Biosciences Inc (RKDA) were sold and 7,749 shares were bought by its insiders, resulting in a net purchase of 7,749 shares.

Arcadia Biosciences Inc (RKDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arcadia Biosciences Inc Insider Transactions

No Available Data

Kevin Comcowich Mailing Address

Above is the net worth, insider trading, and ownership report for Kevin Comcowich. You might contact Kevin Comcowich via mailing address: C/o Arcadia Biosciences, Inc., 202 Cousteau Place, Suite 105, Davis Ca 95618.

Discussions on Kevin Comcowich

No discussions yet.